TRKC, Recombinant, Human, His-Tag (NT-3 Growth Factor Receptor, GP145-TrkC, Trk-C, Neurotrophic Tyrosine Kinase Receptor Type 3, NTRK3, gp145)
Catalog No : USB-500517
572.43€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | TRKC, Recombinant, Human, His-Tag (NT-3 Growth Factor Receptor, GP145-TrkC, Trk-C, Neurotrophic Tyrosine Kinase Receptor Type 3, NTRK3, gp145) | ||
|---|---|---|---|
| Catalog No | USB-500517 | ||
| Supplier’s Catalog No | 500517 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, Insect cells | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 38 | ||
| Storage | -70°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | Purified (~70-90%) | ||
| Form | Supplied as a liquid in 50mM Tris-HCl, pH 7.5, 150mM sodium chloride, 0.25mM DTT, 0.1mM EGTA, 0.1mM EDTA, 0.1mM PMSF, 25% glycerol. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | Purified (~70-90%) | ||
| Description | TRKC is a member of the TRK family of tyrosine kinase receptors and is the high affinity catalytic receptor for the neurotrophin NT-3 (neurotrophin-3). TRKC mediates the multiple cellular effects of the NT-3 neurotrophic factor, which includes neuronal differentiation and survival. TRKC has been implicated in insulin signaling pathway through interactions with the MUSK protein receptor and the VEGF receptor. Mutations in the TRKC gene have been associated with medulloblastomas, secretory breast carcinomas and other cancers. Source: Recombinant protein corresponding to human TRKC, fused to His-Tag at N-terminal expressed in Insect cells. Molecular Weight: ~38kD Specific Activity: 24nmol/min/mg as per activity assay protocol. Endotoxin: <1EU/ug (LAL) Storage and Stability: Aliquot to avoid repeated freezing and thawing and store at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. | ||
© 2020 Imugex All Rights Reserved